RESEARCH PAPER

ARTIST (Asian regional tobacco industry scientist team): Philip Morris’ attempt to exert a scientific and regulatory agenda on Asia

E K Tong¹, S A Glantz²

¹ Division of General Internal Medicine, University of California, San Francisco, San Francisco, California, USA
² Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, California, USA

Correspondence to:
Correspondence to:
Stanton A Glantz PhD
Box 1390, University of California, San Francisco, San Francisco, CA 94143–1390, USA; glantz{at}medicine.ucsf.edu

Objective: To describe how the transnational tobacco industry has collaborated with local Asian tobacco monopolies and companies to promote a scientific and regulatory agenda.

Methods: Analysis of previously secret tobacco industry documents.

Results: Transnational tobacco companies began aggressively entering the Asia market in the 1980s, and the current tobacco industry in Asia is a mix of transnational and local monopolies or private companies. Tobacco industry documents demonstrate that, in 1996, Philip Morris led an organisation of scientific representatives from different tobacco companies called the Asian Regional Tobacco Industry Science Team (ARTIST), whose membership grew to include monopolies from Korea, China, Thailand, and Taiwan and a company from Indonesia. ARTIST was initially a vehicle for PM’s strategies against anticipated calls for global smoke-free areas from a World Health Organization secondhand smoke study. ARTIST evolved through 2001 into a forum to present scientific and regulatory issues faced primarily by Philip Morris and other transnational tobacco companies. Philip Morris’ goal for the organisation became to reach the external scientific and public health community and regulators in Asia.

Conclusion: The Asian tobacco industry has changed from an environment of invasion by transnational tobacco companies to an environment of participation with Philip Morris’ initiated activities. With this participation, tobacco control efforts in Asia face new challenges as Philip Morris promotes and integrates its scientific and regulatory agenda into the local Asian tobacco industry. As the local Asian tobacco monopolies and companies can have direct links with their governments, future implementation of effective tobacco control may be at odds with national priorities.

Abbreviations: ARTIST, Asian Regional Tobacco Industry Science Team; ATIEST, Asian Tobacco Industry ETS Science Team; CECCM, Confederation of European Community Cigarette Makers; CNTC, China National Tobacco Corporation; CORESTA, Cooperation Centre for Scientific Research Relative to Tobacco; ETS, environmental tobacco smoke; IARC, International Agency for Research on Cancer; INFOTAB, International Tobacco Information Center; KGTRI, Korean Ginseng and Tobacco Research Institute; PM, Philip Morris; WHO, World Health Organization

Keywords: China; Japan; Korea; public policy; tobacco smoke pollution

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Chen, A., Glantz, S., Tong, E. (2007). Asian herbal-tobacco cigarettes: "not medicine but less harmful"?. Tobacco Control 16: e3-e3 [Abstract] [Full Text]  
• Bornhauser, A, McCarthy, J, Glantz, S A (2006). German tobacco industry's successful efforts to maintain scientific and political respectability to prevent regulation of secondhand smoke.. Tobacco Control 15: e1-e1 [Abstract] [Full Text]